Providing Insights and Answers
Below are a few samples of our work in helping clients answer important business, marketing and regulatory questions. Interclarity leverages the breadth and depth of its experience – in global health, key therapeutic and diagnostic products, regulatory pathways for essential healthcare products, market research and analytics – to provide the insights and answers that help clients move forward.
Are you missing out on new marketing opportunities? That’s what one of our clients wanted to avoid:
A major pharmaceutical client had reason to believe that two new market segments had emerged and wanted to find empirical evidence to support the new segments using data from a previous segmentation study. If the new segments were supported by the data, the client also needed to develop a means by which to assign new (i.e., out-of-sample) consumers to these segments. In addition, the client wanted to profile the new segments based upon available data, including needs, life goals, and emotional motivators.
Interclarity developed a latent class segmentation model that supported the new segmentation scheme and also constructed a classification model to assign out-of-sample consumers to segments.
Results from this project were used to support the launch of a new product formulation. This project directly addressed the client’s business information needs for a fraction of the cost of a new consumer segmentation study.
Regulatory Pathway Service Quality Measurement
How do product approval applicants view the services provided by a global regulatory pathway for essential healthcare products? What are their expectations for the approval process and service delivery? How do they evaluate the performance of the service provider?
A global, intergovernmental health agency asked Interclarity to implement a service quality survey among healthcare product manufacturers to guide improvements in its regulatory pathway service process.
Interclarity implemented an online survey that quantified applicant expectations – what they really wanted from the review process as well as the minimum levels of acceptable service – and applicants’ performance assessments of the process design and service delivery of the regulatory pathway.
Results from three surveys among manufacturers in three essential healthcare product categories provided evidence to revise and improve the regulatory pathway service process and the service delivery practices of product assessors and manufacturing site inspectors.
Price Sensitivity Analysis
Conventional wisdom said that you could keep raising the prices of products in this category without any slowdown in consumer demand. This, however, made one of our clients uneasy and they decided to investigate.
Facing a major strategic pricing decision for its flagship product, this client needed to answer some important questions: If the client increased the price, would consumers would switch to competitive products and to what extent? What if competitors changed prices – what impacts could be expected for each of the brands?
Using secondary script data with associated out-of-pocket costs, Interclarity constructed a demand model that provided the foundation for the price elasticity analyses.
Study findings provided the client with its first quantitative, model-based evidence that consumers were sensitive to price changes for products in this therapeutic class.
Pro Forma Package Insert Study
What features of a new product are most likely to be important to buyers? What if the final product is different than what was planned – how might that affect buyer preferences?
A major market research agency turned to Interclarity to provide analytical support for an important study for a major pharmaceutical manufacturer. The end-client manufacturer needed to determine how well its new anti-platelet product, still in development, might match up against both branded and generic competitors, given different levels of efficacy and safety for the new product.
Interclarity designed a quantitative study to estimate physician response to alternative label scenarios for the new agent.
Results from this study identified trial results for the new product that were the most influential in physician choice of agents.
Regulatory Stakeholder Meeting Design Consulting
A global, intergovernmental health agency needed to add forward-looking content to an annual joint-meeting with two other agencies and industry stakeholders. Previous meetings had focused on technical updates and process revisions; a new approach was needed to make the meeting more relevant and engaging for attendees, including executive management, middle management and technical specialists from key stakeholder groups.
The lead agency organizing the meeting needed to create and convene a steering committee to assist with content development and a revised meeting structure. Which topics should be added? Which speakers could present in ways that stakeholders would find compelling and relevant? In what ways could the new content complement the traditional technical content of the meeting?
Working with the lead agency, Interclarity: developed the steering committee member selection criteria and assisted in the member selection process; facilitated steering committee teleconferences to generate ideas for plenary session topics; lead the search for potential plenary session speakers; provided consulting support to upgrade the agenda for both the overall meeting and for product-specific breakout sessions; moderated an “Open Forum” meeting session for attendee Q&A and discussion with meeting sponsors.
The new plenary session content and speakers helped raise the awareness of the joint-meeting in the global health community and aligned the program with previous requests from industry stakeholders for a more forward-looking program.